The WHO have recently released a new set of guidelines around strategies for dementia prevention, in which they evaluate potential interventions.
According to a recent study, virtual reality might provide a useful tool for treating dementia. Among other things, it may help improve memory.
A drug that tackles toxic protein buildup in Alzheimer's disease in a novel way has passed phase 1 of clinical trials, which tests safety in humans.
A study uncovers the neuron and immune cell changes that explain why light therapy can reduce toxic brain proteins in mouse models of Alzheimer's disease.
According to a new study, a cell phone game called 'Sea Hero Quest' could assist researchers in identifying people who are more at risk of Alzheimer's.
Experts have defined an under-recognized, newly named condition that mimics Alzheimer's disease and propose guidelines for diagnosing and researching it.
Data from up to 11 years of blood samples confirm neurofilament light protein as a potential noninvasive marker of Alzheimer's disease progression.
Scientists have designed a protein that folds into alpha sheets that can block toxic beta-amyloid in brain cells before it forms into large clumps.
Using brain scans that can detect hallmarks of Alzheimer's could improve diagnosis and clinical care of people with dementia and mild cognitive impairment.
Scientists have found that an experimental drug that failed against cancer may treat dementia instead. However, can they test it in clinical trials?